Error loading player: No playable sources found
67364
Session II: Gene Therapies and New Modalities Part I
Date
September 25, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Development of an icIEF Assay for Monitoring AAV Capsid Proteins and Application to Gene Therapy Products
Xiaoping He, Pfizer, Inc.
Quantitation of Coxsackievirus A21 Viral Proteins in Mixtures of Empty and Full Capsids using Capillary Western
Richard Rustandi, Merck & Co., Inc.
Using Peptide Nucleic Acid Hybridization Probes for Qualitative and Quantitative Analysis of Nucleic Acid Therapeutics by Capillary Electrophoresis
Andrei Hutanu, Ten23
Discussion: 15:00 - 15:15
Development of an icIEF Assay for Monitoring AAV Capsid Proteins and Application to Gene Therapy Products
Xiaoping He, Pfizer, Inc.
Quantitation of Coxsackievirus A21 Viral Proteins in Mixtures of Empty and Full Capsids using Capillary Western
Richard Rustandi, Merck & Co., Inc.
Using Peptide Nucleic Acid Hybridization Probes for Qualitative and Quantitative Analysis of Nucleic Acid Therapeutics by Capillary Electrophoresis
Andrei Hutanu, Ten23
Discussion: 15:00 - 15:15
Session Chairs
Related Products
Spotlight Talk
Single-Run Separation and Quantification of 14 Cannabinoids Using Capillary Electrophoresis
Troubleshooting Workshop
Session Speaker:
Partner Showcase III
The following vendor partners will each present a 5-minute presentation on their company's products and services. Join to learn more about our exhibitors and how they can help better serve you and your customers…
